Tariffs near 17% as 2025 ends — BofA CEO Moynihan sees easing to 15% in 2026

Tariffs near 17% as 2025 ends — BofA CEO Moynihan sees easing to 15% in 2026

NEW YORK, December 31, 2025, 07:31 ET

  • The average effective U.S. tariff rate is now close to its highest level in decades as the year closes.
  • Bank of America CEO Brian Moynihan says trade policy is “starting to de-escalate,” with tariffs settling around 15% for many countries.
  • Businesses are looking for clearer rules on trade and labor as they set 2026 plans.

The average effective U.S. tariff rate has climbed to almost 17% as 2025 closes, up from around 2.5% a year ago, a level not seen since 1935. Reuters

That matters for consumers and companies heading into 2026 because tariffs function as import taxes, raising costs that can feed through to prices and squeeze margins.

It also matters to banks. Higher input costs and policy uncertainty can hit small-business cash flow, while shifting inflation expectations can influence the outlook for interest rates and credit.

Bank of America Chief Executive Brian Moynihan said in a CBS News interview that the administration’s tariff approach was “starting to de-escalate,” with many countries converging toward a 15% rate. “To go from a 10% across the board to 15% for the broad base of countries, not a huge impact,” Moynihan said. CBS News

Moynihan said higher tariff levels could still apply to countries that do not commit to buying more U.S. goods or lowering “non-tariff barriers,” a catch-all for trade obstacles such as quotas, licensing rules or local-content requirements.

He described China as a separate case, pointing to national security concerns tied to rare earths, magnets, batteries and artificial intelligence. He also flagged the U.S.-Mexico-Canada Agreement, or USMCA, as “a different case” ahead of its scheduled review.

For small businesses, Moynihan said tariffs and higher borrowing costs earlier in 2025 weighed on confidence, in part because many smaller firms borrow on floating-rate credit lines that move with interest rates.

He said the pressure point has shifted toward labor availability as immigration rules remain unsettled, a planning problem for firms that need dependable staffing to bid jobs and meet contracts.

Moynihan also pointed to still-firm consumer spending. He said Bank of America’s transaction data showed spending through late November and early December running up roughly 4% to 4.5% from a year earlier, with credit quality holding up, even as inflation remains an irritant for many households.

Some forecasters are less convinced tariffs will quickly retreat. Yahoo Finance reported U.S. tariff rates were set to end 2025 above 15%, and that experts do not expect them to come down much in 2026. Yahoo Finance

Bloomberg earlier reported Moynihan’s assessment that tariff policy is moving toward “de-escalation, not escalation,” and that Bank of America sees an average 15% tariff level for a broad base of countries, with higher rates for holdouts. Bloomberg

The direction of travel matters as much as the level. Even if headline tariff rates stabilize, companies will watch whether rules stay predictable enough to unlock hiring and investment plans that were postponed during bouts of trade-policy uncertainty.

Stock Market Today

  • Vanda's tradipitant wins FDA nod for motion sickness; VNDA stock jumps after-hours
    December 31, 2025, 9:38 AM EST. Vanda Pharmaceuticals' candidate tradipitant has received FDA approval to prevent vomiting from motion sickness, under the brand Nereus. The decision follows three clinical studies, including two phase III real-world trials conducted at sea named Motion Syros and Motion Serifos, backing the therapy's efficacy. VNDA shares rose about 18% in after-hours trade and extended gains in pre-market trading. Vanda licensed tradipitant from Eli Lilly and is exploring its use in gastroparesis and for nausea linked to GLP-1 receptor agonists in obesity and diabetes therapies. Separately, the company operates under a collaborative framework with the FDA to resolve disputes around Hetlioz and tradipitant, with an expedited re-review extended to Dec 5, 2025.
Grab stock dips before the bell on final trading day of 2025 — what GRAB investors are watching
Previous Story

Grab stock dips before the bell on final trading day of 2025 — what GRAB investors are watching

BitMine Immersion (BMNR) Stock Today: Ether Treasury Update Keeps Shares in Focus Ahead of Jan. 15 Vote
Next Story

BitMine Immersion (BMNR) Stock Today: Ether Treasury Update Keeps Shares in Focus Ahead of Jan. 15 Vote

Go toTop